期刊文献+

M蛋白致敏树突状细胞诱导的抗骨髓瘤细胞效应

Myeloma protein-pusled dendritic cells induced anti-myeloma cells activity
下载PDF
导出
摘要 目的:探讨M蛋白致敏树突状细胞(DC)诱导激活的自体T细胞对骨髓瘤细胞特异性免疫杀伤效应。方法:取多发性骨髓瘤(MM)患者外周血单核细胞经GM-CSFI、L-4和TNF-α体外联合诱导生成DC,用DEAE-纤维素提取法自MM患者血清中分离、纯化M蛋白。以M蛋白冲击致敏DC(同时设未致敏的DC为对照),流式细胞术分析DC免疫表型,并与自体T淋巴细胞进行混合淋巴细胞反应5。1Cr释放法测定T细胞对不同靶细胞(患者骨髓瘤细胞、U266细胞)的杀伤活性。结果:经M蛋白致敏的DC激发自体T细胞增殖的能力明显强于未致敏的DC(P<0.05);同时负载M蛋白DC激活的T细胞杀伤活性也明显强于对照组(P<0.01),而两组T细胞对U266细胞均无明显杀伤活性。结论:M蛋白致敏DC能有效诱导自体T细胞对骨髓瘤细胞的特异性杀伤作用。 Objective: To investigate the anti-myeloma cells specific immune activity induced by myeloma protein-pusled dendritic cells(DCs). Methods: DCs were obtained from peripheral blood(PB) of multiple myeloma(MM) patients after co-culture with GM-CSF,IL-4 and TNF-α. The phenotype of DCs was examined by flow cytometry. Host lymphocytes were stimulated with DCs pulsed with myeloma protein acquired from serum of MM patients on DEAE-celluose; lymphocytes treated with unpulsed-DC served as control. [^3 H]-thymidine incorporation and 4 h ^51 Cr-release assay were used to detect the proliferation and cytotoxicity against different targets(auto-myeloma cells,U266 cells) by T lymphocytes. Results: In vitro proliferation and cytotoxicity of T lymphocytes activated by myeloma protein pulsed-DCs were greater than those of T lymphocytes in the control group(P〈0.01). T lymphocytes in neither of the 2 groups had notable cytotoxicity against U266 cells. Conclusion: DCs pulsed by myeloma protein can effectively induce specific cytotoxicity of T lymphocytes against myeloma cells.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2006年第6期624-627,共4页 Academic Journal of Second Military Medical University
基金 江苏省淮安市医学科研计划项目(WX200505)~~
关键词 多发性骨髓瘤 M蛋白 树突细胞 T淋巴细胞 multiple myeloma myeloma protein dendritic cells T-lymphocytes
  • 相关文献

参考文献10

二级参考文献62

  • 1Choudhury A,Blood,1999年,93卷,3期,780页 被引量:1
  • 2Wang J L,The J Immunol,1998年,161卷,5516页 被引量:1
  • 3Gong J,Gene Therapy,1997年,4卷,1023页 被引量:1
  • 4Hsu F J,Nature Med,1996年,2卷,1期,52页 被引量:1
  • 5Bergui L, Schena M, Gaidano G, et al. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma [ J ]. J Exp Med, 1989, 170(2):613-618. 被引量:1
  • 6Caux C, Vanbervliet B, Massacrier C,et al. CD34 + hematopoietic piogenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF-αt[ J]. J Exp Med, 1996, 184: 695-706. 被引量:1
  • 7Yang S, Darrow TL, Vervaert CE, et al. Immuootherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow[J]. Cell Immunol, 1997, 179( 1 ): 84 -95 . 被引量:1
  • 8Pfeiffer S, Gooding RP, Apperley JF,et al. Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors[J]. BrJ Haematol, 1997, 98(4): 973-982. 被引量:1
  • 9Wen Y J, Min R, Tricot G, et al. Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immumotherapy[J]. Blood, 2002, 99(9): 3 280-3 285. 被引量:1
  • 10Grabbe S, Beissert S, Schwarz T, et al. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?[J]. Immunol Today, 1995,16(3): 117-121. 被引量:1

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部